vs
IRIDEX CORP（IRIX）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
IRIDEX CORP的季度营收约是RIVERVIEW BANCORP INC的1.0倍（$14.7M vs $14.0M），RIVERVIEW BANCORP INC同比增速更快（10.4% vs -69.7%），过去两年RIVERVIEW BANCORP INC的营收复合增速更高（24.6% vs 11.9%）
IRIDEX Corporation是一家全球性医疗科技企业，主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备，产品供应至北美、欧洲、亚太等地区的医疗机构与诊所，为眼部疾病治疗和医美项目提供微创解决方案。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
IRIX vs RVSB — 直观对比
营收规模更大
IRIX
是对方的1.0倍
$14.0M
营收增速更快
RVSB
高出80.1%
-69.7%
两年增速更快
RVSB
近两年复合增速
11.9%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $14.7M | $14.0M |
| 净利润 | — | $1.4M |
| 毛利率 | 37.2% | — |
| 营业利润率 | — | 12.4% |
| 净利率 | — | 9.8% |
| 营收同比 | -69.7% | 10.4% |
| 净利润同比 | — | 11.8% |
| 每股收益（稀释后） | — | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRIXRVSB
| Q4 25 | $14.7M | $14.0M | ||
| Q3 25 | $12.5M | $13.6M | ||
| Q2 25 | $13.6M | $13.3M | ||
| Q1 25 | $11.9M | $12.9M | ||
| Q4 24 | $12.7M | $12.7M | ||
| Q3 24 | $11.6M | $12.8M | ||
| Q2 24 | $12.6M | $12.2M | ||
| Q1 24 | $11.8M | $9.0M |
净利润IRIXRVSB
| Q4 25 | — | $1.4M | ||
| Q3 25 | $-1.6M | $1.1M | ||
| Q2 25 | $-994.0K | $1.2M | ||
| Q1 25 | $-1.7M | $1.1M | ||
| Q4 24 | $-834.0K | $1.2M | ||
| Q3 24 | $-1.9M | $1.6M | ||
| Q2 24 | $-2.7M | $966.0K | ||
| Q1 24 | $-3.5M | $-3.0M |
毛利率IRIXRVSB
| Q4 25 | 37.2% | — | ||
| Q3 25 | 32.1% | — | ||
| Q2 25 | 34.5% | — | ||
| Q1 25 | 42.5% | — | ||
| Q4 24 | 44.0% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 40.7% | — | ||
| Q1 24 | 37.9% | — |
营业利润率IRIXRVSB
| Q4 25 | — | 12.4% | ||
| Q3 25 | -11.3% | 10.2% | ||
| Q2 25 | -6.9% | 11.7% | ||
| Q1 25 | -1.7% | 11.3% | ||
| Q4 24 | -3.9% | 12.4% | ||
| Q3 24 | -16.1% | 15.5% | ||
| Q2 24 | -20.9% | 10.0% | ||
| Q1 24 | -28.0% | -47.5% |
净利率IRIXRVSB
| Q4 25 | — | 9.8% | ||
| Q3 25 | -12.6% | 8.1% | ||
| Q2 25 | -7.3% | 9.2% | ||
| Q1 25 | -14.2% | 8.9% | ||
| Q4 24 | -6.6% | 9.7% | ||
| Q3 24 | -16.7% | 12.2% | ||
| Q2 24 | -21.2% | 7.9% | ||
| Q1 24 | -29.5% | -34.7% |
每股收益（稀释后）IRIXRVSB
| Q4 25 | — | $0.07 | ||
| Q3 25 | $-0.09 | $0.05 | ||
| Q2 25 | $-0.06 | $0.06 | ||
| Q1 25 | $-0.10 | $0.05 | ||
| Q4 24 | $-0.05 | $0.06 | ||
| Q3 24 | $-0.12 | $0.07 | ||
| Q2 24 | $-0.16 | $0.05 | ||
| Q1 24 | $-0.21 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.0M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $164.2M |
| 总资产 | $29.2M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IRIXRVSB
| Q4 25 | $6.0M | $28.6M | ||
| Q3 25 | $5.6M | $32.8M | ||
| Q2 25 | $6.8M | $34.2M | ||
| Q1 25 | $7.2M | $29.4M | ||
| Q4 24 | $2.4M | $25.3M | ||
| Q3 24 | $3.9M | $31.0M | ||
| Q2 24 | $4.1M | $27.8M | ||
| Q1 24 | $5.4M | $23.6M |
总债务IRIXRVSB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.0M | — | ||
| Q3 24 | $1.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IRIXRVSB
| Q4 25 | — | $164.2M | ||
| Q3 25 | $4.7M | $163.5M | ||
| Q2 25 | $6.1M | $162.0M | ||
| Q1 25 | $852.0K | $160.0M | ||
| Q4 24 | $2.1M | $158.3M | ||
| Q3 24 | $2.6M | $160.8M | ||
| Q2 24 | $4.2M | $155.9M | ||
| Q1 24 | $6.5M | $155.6M |
总资产IRIXRVSB
| Q4 25 | $29.2M | $1.5B | ||
| Q3 25 | $28.4M | $1.5B | ||
| Q2 25 | $31.6M | $1.5B | ||
| Q1 25 | $34.2M | $1.5B | ||
| Q4 24 | $29.1M | $1.5B | ||
| Q3 24 | $30.2M | $1.5B | ||
| Q2 24 | $31.2M | $1.5B | ||
| Q1 24 | $34.1M | $1.5B |
负债/权益比IRIXRVSB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.48× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-736.0K |
| 自由现金流率自由现金流/营收 | — | -5.2% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | — | $20.4M |
8季度趋势，按日历期对齐
经营现金流IRIXRVSB
| Q4 25 | — | $-506.0K | ||
| Q3 25 | $-1.2M | $16.8M | ||
| Q2 25 | $-397.0K | $-697.0K | ||
| Q1 25 | $-1.1M | $8.3M | ||
| Q4 24 | $-1.2M | $2.2M | ||
| Q3 24 | $-3.1M | $764.0K | ||
| Q2 24 | $-1.3M | $5.4M | ||
| Q1 24 | $-1.6M | $12.8M |
自由现金流IRIXRVSB
| Q4 25 | — | $-736.0K | ||
| Q3 25 | $-1.2M | $16.4M | ||
| Q2 25 | $-410.0K | $-773.0K | ||
| Q1 25 | $-1.2M | $5.6M | ||
| Q4 24 | $-1.2M | $1.9M | ||
| Q3 24 | $-3.1M | $-1.4M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | $-1.7M | $7.1M |
自由现金流率IRIXRVSB
| Q4 25 | — | -5.2% | ||
| Q3 25 | -9.4% | 120.1% | ||
| Q2 25 | -3.0% | -5.8% | ||
| Q1 25 | -9.8% | 43.1% | ||
| Q4 24 | -9.8% | 15.0% | ||
| Q3 24 | -26.5% | -11.3% | ||
| Q2 24 | — | 43.7% | ||
| Q1 24 | -14.0% | 79.0% |
资本支出强度IRIXRVSB
| Q4 25 | — | 1.6% | ||
| Q3 25 | 0.1% | 2.9% | ||
| Q2 25 | 0.1% | 0.6% | ||
| Q1 25 | 0.1% | 21.0% | ||
| Q4 24 | 0.1% | 2.4% | ||
| Q3 24 | 0.0% | 17.3% | ||
| Q2 24 | 0.0% | 0.9% | ||
| Q1 24 | 0.0% | 62.0% |
现金转化率IRIXRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
